Search results
Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 6 days agoBesides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of...
Novo Nordisk earnings are coming during a weight loss drugs sales surge. Here are 3 things to watch
Quartz· 4 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy,...
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 5 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 6 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
‘The right people:’ Florida man gets free financial lifeline he never knew existed
WKMG ClickOrlando· 4 days agoDonnie Graham, a 77-year-old Florida retiree on a fixed income, found himself in need of a place to...
'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse
The Day· 3 days agoThe American Heart Association calls them "game changers." Oprah Winfrey says they're "a gift." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Obesity ...
What if I can't find a doctor? Physician shortage will change how Americans receive care.
USA Today· 4 days agoA whopping 83 million Americans don't have sufficient access to a primary care provider. Within a...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks· 6 days agoInvestors are expected to focus on top and bottom-line growth when Collegium Pharmaceutical (COLL Quick QuoteCOLL - Free Report) reports first-quarter 2024 results on May 9, 2024. Collegium ...
The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook
FOX21 Colorado Springs· 3 days agoGlobal health company The Cigna Group (NYSE: CI) today reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses. "Our strong first quarter ...
Q1 2024 Blueprint Medicines Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoImportantly, unlike last year, we expect these patients will be able to stay on therapy for the rest of the year due to changes to the out-of-pocket cap as part of Medicare